Cointime

VitaDX

company

About

VitaDX develops a non-invasive solution for early bladder cancer diagnosis.

  • 11 - 50

Highlights

Total Funding Amount
€3M
Funding Rounds
2
Investors
3

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
€2M
Industries
Biotechnology
Founded date
Jan 1, 2014
Number Of Employee
11 - 50
Operating Status
Active

VitaDX is a startup applying artificial intelligence to the healthcare sector, and more specifically to the early diagnosis of cancer by exploiting fluorescence imaging in favor of a first product, VisioCyt®, dedicated to the detection of cancer of the bladder. This solution will allow the diagnosis of bladder cancer from a simple urine sample to improve the performance of urinary cytology conventionally used in first intention.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
€3M
VitaDX has raised a total of €3M in funding over 2 rounds. Their latest funding was raised on Sep 4, 2020 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 4, 2020 Debt Financing €2M 2 — — Detail
Sep 4, 2020 Series Unknown €1M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
3
VitaDX is funded by 3 investors. CIC Ouest and Banque Populaire Grand-Ouest are the most recent investors.
Investor Name Lead Investor Funding Round
CIC Ouest — Debt Financing
Banque Populaire Grand-Ouest — Debt Financing
FFBB MANAGEMENT — Series Unknown
Cointime
Chủ Đề
Công Ty